Generics - Biotechnology, rituximab

Filter

Current filters:

Biotechnologyrituximab

Popular Filters

Natco in biogenerics in deal with Mabxience; plans generic launches in South Africa

06-11-2011

Hyderabad, India-based generic drugmaker Natco Pharma (524816: BY) has entered into an exclusive agreement…

Asia-PacificbevacizumabBiotechnologyetanerceptGenericsLicensingMabxienceMarkets & MarketingNatco PharmaRest of the Worldrituximabtrastuzumab

Back to top